Australian

Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa’s Second COVID-19 Therapeutic Development Program

Adelaide, July 25, 2020:  (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO…

4 years ago

Australian CRO, Avance Clinical is Uniquely Positioned for COVID-19 Vaccines and Therapies Clinical Trials

New Delhi, March 22, 2020: Australian CRO Avance Clinical said today that Australia's fast regulatory approval environment, key opinion leader…

5 years ago